SAVA241122C49000
- 0.10
- 0.000.00%
Cassava Sciences Newsroom
Express News | Cassava Sciences Shares Fall 4% After 84% Slump in Previous Session
Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)
This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Cassava Sciences Price Target Announced at $116.00/Share by HC Wainwright & Co.
Cassava Sciences Analyst Ratings
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Tuesday; Cassava Sciences to Advance, MicroStrategy to Decline
H.C. Wainwright Downgrades Cassava Sciences(SAVA.US) to Hold Rating
Express News | Cassava Sciences, Inc. : H.c. Wainwright Cuts to Neutral From Buy
Cassava Sciences Options Spot-On: On November 25th, 168.87K Contracts Were Traded, With 300.78K Open Interest
On November 25th ET, $Cassava Sciences(SAVA.US)$ had active options trading, with a total trading volume of 168.87K options for the day, of which put options accounted for 34.72% of the total
12 Health Care Stocks Moving In Monday's Pre-Market Session
Cassava Sciences Plummets Over 80% on Alzheimer's Trial Fail
Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October
Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
Trending Stocks Today | Quantum Shoots up 152.57%
November 25th - US stocks trending in regular trading hours.Gainers: $Quantum(QMCO.US)$ shoots up 152.57% to $23.06 with a turnover of $286.03 million. $QMMM Holdings(QMMM.US)$ surges 50.68% to $1.13
Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings
U.S. stocks react | Simufilam's phase 3 Alzheimer's trial did not meet its endpoints, leading to a more than 84% plunge in cassava sciences (SAVA.US).
As of the time of publication, the stock has fallen by over 84%, reporting $4.06.
JonesTrading Maintains Cassava Sciences(SAVA.US) With Hold Rating
JonesTrading Keeps Their Hold Rating on Cassava Sciences (SAVA)
Sector Update: Health Care Stocks Edge Higher Premarket Monday